期刊文献+

多囊卵巢综合征患者血清对氧磷酯酶1活性、氧化应激与胰岛素抵抗的关系 被引量:6

The correlation of serum paraoxonase-l and oxidative stress with insulin resistance in patients with polycystic ovary syndrome
原文传递
导出
摘要 目的探讨对氧磷酯酶1(PON-1)活性、氧化应激在多囊卵巢综合征(PCOS)患者发生胰岛素抵抗(IR)中的作用。方法 41例PCOS患者分为肥胖组17例和非肥胖组24例,另有20名健康女性纳入正常对照组。所有研究对象均行口服糖耐量试验(OGTT)和胰岛素释放试验,使用稳态模型评价IR及胰岛β细胞分泌功能,空腹静脉取血检测丙二醛(MDA)、超氧化物歧化酶(SOD)活性及PON-1活性。结果 (1)PCOS非肥胖组和PCOS肥胖组的空腹胰岛素、餐后2小时血糖及胰岛素、HOMA-IR及HOMA-β均高于正常组(P<0.05),且PCOS肥胖组的空腹胰岛素、餐后2小时血糖及胰岛素、HOMA-IR均高于PCOS非肥胖组(P<0.05)。(2)PCOS非肥胖组和PCOS肥胖组的MDA、SOD及PON-1与正常组比较差异有统计学意义(P<0.05);PCOS肥胖组的SOD显著低于PCOS非肥胖组(P<0.01),而MDA及PON-1两组之间差异无统计学意义(P>0.05)。(3)相关分析显示:在PCOS非肥胖组,SOD与PON-1正相关(r=0.417,P<0.05),SOD与IR负相关(r=-0.492,P<0.05)。结论 PCOS患者无论肥胖与否,均存在餐后血糖升高、PON-1活性降低、氧化应激、IR,且肥胖患者更为严重;PCOS患者的氧化应激与IR相关。 Objective To observe the role of paraoxonase-1 and oxidative stress in pathogenesis of insulin resistance in patients with polycystic ovary syndrome (PCOS). Methods 41 PCOS patients divided into obese group and non-obese group with 20 healthy volunteers as a control. The 75g oral glucose tolerance test (OGTT) and insulin releasing test (IRT) were performed. The insulin resistance and β-eell function were estimated with homeostasis model assessment (HOMA). The fasting serum concentration of malondialdehyde (MDA), and the activities of superoxide dismutase (SOD) and paraoxonase-1 (PON-1) were assayed. Results (1) The levels of fasting plasma insulin, 2 hour plasma glucose and insulin, the index of insulin resistance (HOMA-IR) and β-cell function (HOMA-β) were significantly higher in PCOS patients of both non-obese group and obese group than in healthy controls(all P〈0.05). HOMA-β was not different between non-obese group and obese group in PCOS patients(P〉0.05), while the the levels of BMI, 2hPG, Fins, 2hIns, and HOMA-IR were significantly higher in obese group than in non-obese group(all P〈0. 05). (2)The PCOS patients in both non-obese group and obese group showed higher MDA and lower SOD and PON-1 than in healthy controls(P〈0.05). The serum concentration of MDA and the activity PON-1 showed no differences between non-obese group and obese group in PCOS patients (both, P^0.05), but The activity of SOD was significantly lower in obese group than in non-obese group (P〈0. 01). (3) SOD had a positive correlation with PON-I(r=0. 417, P=0.043), and a negative correlation with HOMA IR(r=0. 492, P=0. 015)in non-obese PCOS group. Conclusion The PCOS patients has an increased postprandial plasma glucose, impared PON-1 activity, oxidative stress, insulin resistance, and high level of plasma insulin in non-obese and especially in obese subgroup. Insulin resistance is related to oxidative stress in patients with PCOS.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2011年第2期97-100,共4页 Chinese Journal of Diabetes
关键词 多囊卵巢综合征 胰岛素抵抗 氧化应激 对氧磷酯酶1 Polycystic ovary syndrome Insulin resistance Oxidative stress Paraoxonase-1
  • 相关文献

参考文献14

  • 1Kelly CJ,Connell JM,Cameron IT,et al.The long term health consequences of polycystic ovary syndrome.Br J Obstet Gynecol,2000,107:1327-1338.
  • 2Ovalle F,Azziz R.Insulin resistance,polycystic ovary syndrome,and type 2 diabetes mellitus.Fertil Steril,2002,77:1095-1105.
  • 3Houstis N,Rosen ED,Lander ES.Reactive oxygen species have a causal role in multiple forms of insulin resistance.Nature,2008,440:944-948.
  • 4李美芝,李蓉.多囊卵巢综合征诊断的金标准:鹿特丹标准?[J].中国实用妇科与产科杂志,2007,23(9):657-659. 被引量:160
  • 5周志俊,邬红梅,胡云平,薛寿征.血清对氧磷酶活性测定方法研究[J].中国公共卫生,2000,16(4):303-304. 被引量:17
  • 6Sabuncu T,Vural H,Harma M,et al.Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease.Clin biochem,2001,34:407-413.
  • 7Fenkci V,Fenkci S,Yilmazer M,et al.Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease.Fertil Steril,2003,80:123-126.
  • 8Evans JL,Goldfine ID,Maddux BA,et al.Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?Diabetes,2003,52:1-8.
  • 9Legro RS,Kunselman AR,Dodson WC,et al.Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome:a prospective,controlled study in 254 affected women.J Clin Endocrinol Metab,1999,84:165.
  • 10Gonzalez F,Rote NS,minium J,et al.Reactive oxygen species-induced oxidatuve stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.J Clin Endocrinol Metab,2006,91:336-340.

二级参考文献31

  • 1王青定,孙曼霁.人血清中的对氧磷酶[J].生物化学与生物物理进展,1996,23(3):217-221. 被引量:2
  • 2Humbert R, Alder DA, Disteche CM, et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet, 1993,3:73-76.
  • 3Furlong CE, Richter RJ, Seidel SL, et al. Role of genelic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos paraoxon. Am J Hum Genet, 1998,43:230-238.
  • 4Mcelveen J, Mackness MI, Colley CM, et al. Distribution of the paraoxon hydrolytic activity in the serum of patients after myocardiol infarction. Clin Chem, 1986,32 : 671-673.
  • 5Mackness B, Durrington PN, Abuashia B, et al. Low paraoxonase activity in type Ⅱ diabetes mellitus complicated by retinopathy. Clin Sci (Colch), 2000,98 : 355-363.
  • 6Inoue M, Suehiro T, Nakamura T, et al. Serum arylesterase/diazoxon ase activity and genetic polymorphism in patients with type 2 diabetes. Metabolism, 2000,49:1400-1405.
  • 7Kohno M, Ohmori K, Wada Y, et al. Inhibition by eicosapentaenoic acid of oxidized-LDL-and lysophosphatidylcho-line-in-duced human coronary artery smooth muscle cell production of endothelin. J Vasc Res, 2001,38:379-388.
  • 8Eaurenti O, Vingolo EM, Desideri GB, et al. Increase levels of plasma endotbelin-1 in non-insulin dependent diabetic palients with retinopathy but without other diabetes related organ damage. Exp Clin Endocrinol Diabetes, 1997,105suppl 2:40-47.
  • 9Reiner E. Recommendations of the IUBUM Nomenclature Committee:Comments Concerning Classification and Nomenclature of Esterases Hydrolysing Organophosphorus Compounds. Chem - biol. Interactions 1993; 87:15-16
  • 10Eckerson HW, et al. The Human Serum Paraoxonase Polymorphism;Identification of Phenotypes by their Response to Salts. Am. J. Hum.Genet 1983; 35: 214

共引文献178

同被引文献59

  • 1郁琦.多囊卵巢综合征诊治标准专家共识[J].中国实用妇科与产科杂志,2007,23(6):474-474. 被引量:114
  • 2Karadeniz M,Erdog∨an M,Tamsel S,et al.Oxidative stress markers in young patients with polycystic ovary syndrome,the relationship between insulin resistances[J].Exp Clin Endocrinol Diabetes,2008,116(4):231-235.
  • 3Cussons A J,Watts G F,Burke V,et al.Cardiometabolic risk in polycystic ovary syndrome:a comparison of different approaches to defining the metabolic syndrome[J].Hum Reprod,2008,23(10):2352-2358.
  • 4Diamanti-Kandarakis E,Xyrafis X,Boutzios G,et al.Pancreatic β-cells dysfunction in polycystic ovary syndrome[J].Panminerva Med,2008,50(4):315-325.
  • 5Glazier M G,Bowman M A.A Review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy[J].Arch Intern Med,2001,161:1161-1172.
  • 6Shih D M,Gu L,Xia Y-R,et al.Mice lacking serum paraoxonase are susceptibleto organophosphate toxicity and atherosclerosis[J].Nature,1998,394:284-287.
  • 7Watson A D,Berliner J A,Harna S Y,et al.Protective effcct of high lipoprotein associated paraoxonase:Inhibition of the biological activity of minimally oxidized low density lipoprotein[J].J Clin Invest,1995,96(6):2882-2891.
  • 8Mackness M I,Arrols,Durrington P N.Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein[J].FEBS Lett,1991,286:152-154.
  • 9Bert N,La Du,Michael Aviramb,et al.On the physiological role(s)of the paraoxonases[J].Chemico-Biological Interactions,1999,119:379-388.
  • 10张丹,罗万英,廖华,王成芳,孙莹.氧化应激与多囊卵巢综合征的关系初探[J].四川大学学报(医学版),2008,39(3):421-423. 被引量:15

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部